SQSTM1 Mutations in french patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis

JAMA Neurology

Volumn 70, Issue 11, 2013, Pages 1403-1410

  Le Ber, Isabelle ^a,b,c   Camuzat, Agnès ^a,b,c   Guerreiro, Rita ^d   Bouya Ahmed, Kawtar ^a,b,c   Bras, Jose ^d   Nicolas, Gael ^e   Gabelle, Audrey ^f   Didic, Mira ^g   De Septenville, Anne ^h   Millecamps, Stéphanie ^a,b,c   Lenglet, Timothée ^a   Latouche, Morwena ^a,b,c   Kabashi, Edor ^a,b,c,g   Campion, Dominique ^e   Hannequin, Didier ^e   Hardy, John ^d   Brice, Alexis ^a,b,c,g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f GUI DE CHAULIAC HOSPITAL   (France)

^g INSERM   (France)

^h INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P62;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BEHAVIOR DISORDER; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FRANCE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PAGET BONE DISEASE; PHENOTYPE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SQSTM1 GENE; VERY ELDERLY;

EID: 84888882093     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.3849     Document Type: Article

References (27)

1. Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet. 2002;70(6):1582-1588.
2. Komatsu M, Kaygeyama S. Ichimura Y. p62/SQSTM1/A170: Physiology and pathology. Pharmacol Res. 2012;66(6):457-462.
3. Al-Sarraj S, King A, Troakes C, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122(6):691-702.
4. Fecto F, Yan J, Vemula SP, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440-1446.
5. Hirano M, Nakamura Y, Saigoh K, et al. Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology. 2013;80(5):458-463.
6. Rubino E, Rainero I, Chiò A, et al; TODEM Study Group. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. 2012;79(15):1556-1562.
7. Le Ber I, Guedj E, Gabelle A, et al; French research network on FTD/FTD-MND. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain. 2006;129(pt 11):3051-3065.
8. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
9. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(suppl):96- 107.
10. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-1760.
11. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297-1303.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
13. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources; 1988.
14. Thuillard F, Assal G. Données neuropsychologiques chez le sujet âgé normal. In: Habib M, Joanette Y, Puel M, eds. Démences et syndromes démentiels: approche neuropsychologique. Paris, France: Masson; 1991:125-133.
15. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-1626.
16. Van der Linden M, Coyette F, Poitrenaud J, et al. L'épreuve de rappel libre/rappel indicé de 16 items (RL/RI-16). In: Van der Linden M, ed. L'évaluation des troubles de la mémoire. Marseille, France: Solal; 2004:25-47.
17. Rey A. Test de copie et de reproduction de mémoire de figures géométriques complexes. Paris, France: ECPA; 1959.
18. Deloche G, Hannequin D, Dordain M, et al. Picture confrontation oral naming: performance differences between aphasics and normals. Brain Lang. 1996;53(1):105-120.
19. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(pt 9):2456-2477.
20. Teyssou E, Takeda T, Lebon V, et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol. 2013;125(4):511-522.
21. Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91(2):97-113.
22. Michou L, Morissette J, Gagnon ER, et al. Novel SQSTM1 mutations in patients with Paget's disease of bone in an unrelated multiethnic American population. Bone. 2011;48(3):456-460.
23. Tanji K, Zhang HX, Mori F, Kakita A, Takahashi H, Wakabayashi K. p62/sequestosome 1 binds to TDP-43 in brains with frontotemporal lobar degeneration with TDP-43 inclusions. J Neurosci Res. 2012;90(10):2034-2042.
24. Johnson JO, Mandrioli J, Benatar M, et al; ITALSGEN Consortium. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857-864.
25. Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223-226.
26. Albagha OM, Visconti MR, Alonso N, et al. Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet. 2010;42(6):520-524.
27. Fecto F, Siddique T. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia. Muscle Nerve. 2012;45(2):157-162.